Orencia is a biologic that was approved in 2017 for the treatment of psoriatic arthritis. 

What is Orencia

Orencia (also known by its generic name abatacept) was approved by the FDA in July 2017 for the treatment of adults with active psoriatic arthritis. It is also approved to treat rheumatoid arthritis and juvenile idiopathic arthritis.

Orencia may be given as an intravenous infusion in your doctor's office or as a self-administered injection under the skin. Please speak with your health care provider about the best way for you to receive Orencia.

To learn more, please visit the Orencia website.

Illustrated knee pain to represent psoriatic arthritis.

FDA Approves Orencia Biologic for Psoriatic Arthritis

Learn how Orencia might be a treatment option for you and your psoriatic arthritis.

Get the facts
Illustrated graphic of people around a rocket ship and computer.

Advance Weekly

Get the latest news on new treatment options from NPF.

Stay up to date

Learn More About Your Treatment Options

The Patient Navigation Center is here to provide personalized information about your psoriasis and psoriatic arthritis treatment.

Contact a Patient Navigator today

Stay in the Know

Expert tips, can’t-miss events, and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity NavigatorCommunity Health Charities logo

Copyright © 1996-2023 National Psoriasis Foundation/USA

Duplication, rebroadcast, republication, or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).

NPF does not endorse or accept any responsibility for the content of external websites.

NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.